International Clinical Trial: Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220785) titled 'Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy' on Oct. 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Regeneron Pharmaceuticals

Condition: Generalized Lipodystrophy

Intervention: Drug: Mibavademab

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: January 30, 2026

Target Sample Size: 28

To know more, visit https://clinicaltrials.gov/study/NC...